发明名称 KIAA1456 EXPRESSION PREDICTS SURVIVAL IN PATIENTS WITH COLON CANCER
摘要 The invention relates to methods for deciding on the therapy in a subject suffering from colorectal cancer as well as for predicting the clinical outcome of a patient which suffers from colorectal cancer based on the expression level of KIAA1456 comprising determining the expression level of the KIAA1456 gene. The invention relates as well to kits and uses thereof comprising reagents adequate for the determination of the expression level of the KIAA1456 gene.
申请公布号 CA2835721(A1) 申请公布日期 2012.11.15
申请号 CA20122835721 申请日期 2012.05.11
申请人 TRASLATIONAL CANCER DRUGS PHARMA, S.L. 发明人 LACAL SANJUAN, JUAN CARLOS;VALDES MORA, FATIMA
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址